Research Paper Volume 16, Issue 3 pp 2679—2701
Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma
Figure 2. CRGs expression in progression of ccRCC. (A) Expression of CRGs in normal tissues and tumors samples from GSE40435 by (B) stage and (C) sex.